Femasys Stock (NASDAQ:FEMY)
Previous Close
$1.12
52W Range
$0.25 - $4.75
50D Avg
$1.09
200D Avg
$1.20
Market Cap
$24.90M
Avg Vol (3M)
$175.37K
Beta
-2.81
Div Yield
-
FEMY Company Profile
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.